Search

Your search keyword '"Racanelli, Vito"' showing total 1,572 results

Search Constraints

Start Over You searched for: Author "Racanelli, Vito" Remove constraint Author: "Racanelli, Vito"
1,572 results on '"Racanelli, Vito"'

Search Results

103. Coronavirus Disease 2019: A Brief Review of the Clinical Manifestations and Pathogenesis to the Novel Management Approaches and Treatments

104. Actors on the Scene: Immune Cells in the Myeloma Niche

106. BL1391: an established cell line from a human malignant peripheral nerve sheath tumor with unique genomic features

107. The Latest Findings of PD-1/PD-L1 Inhibitor Application in Gynecologic Cancers

110. Early Disease and Low Baseline Damage as Predictors of Response to Belimumab in Patients With Systemic Lupus Erythematosus in a Real‐Life Setting

114. MicroRNAs-Based Nano-Strategies as New Therapeutic Approach in Multiple Myeloma to Overcome Disease Progression and Drug Resistance

116. Bortezomib Treatment Modulates Autophagy in Multiple Myeloma

117. HB-EGF–EGFR Signaling in Bone Marrow Endothelial Cells Mediates Angiogenesis Associated with Multiple Myeloma

118. Early echocardiographic detection of left ventricular diastolic dysfunction in patients with systemic lupus erythematosus asymptomatic for cardiovascular disease

120. Adhesion-Mediated Multiple Myeloma (MM) Disease Progression: Junctional Adhesion Molecule a Enhances Angiogenesis and Multiple Myeloma Dissemination and Predicts Poor Survival

121. Carcinogenesis and Metastasis in Liver: Cell Physiological Basis

123. The world's most respected companies

124. Buy GM: yes, there's huge risk... and potentially huge reward

125. GE's moment

126. The world's most respected companies: A good name above all

127. Summer wind blows hot for stocks

129. The latest gee-whiz forecasts for 3G

130. Fun in the Germany Sun

132. Rally kicks off the fourth quarter

133. Triple crown: Some companies generate more sales, more cash and more returns for investors. An annual ranking

134. Pricey club: Luxury-goods makers are back in style-but are they too rich?

135. The best in class: here's our annual dean's list of the best-performing companies

136. Best of all: Barron's 500, a report card on how companies perform for investors, is topped by Best Buy

138. Waiting for '02: our panelists handicap the recovery in stocks on the Continent

139. Reality check: the year's Barron's 500 deflates the effects of the burst bubble

141. EEcacy, Safety, and Predictor of Response to Belimumab in a Large Nationwide Cohort Study of Patients with Active Systemic Lupus Erythematosus

142. Suspected Pericardial Tuberculosis Revealed as an Amyloid Pericardial Mass

143. High-Risk Multiple Myeloma: Integrated Clinical and Omics Approach Dissects the Neoplastic Clone and the Tumor Microenvironment

144. FRI0199 EFFECTIVENESS AND SAFETY OF BELIMUMAB IN PATIENTSWITH ACTIVE SYSTEMIC LUPUS ERYTHEMATOSUS: RESULTS FROM A LARGE, NATIONWIDE, MULTICENTRIC STUDY

146. Clinical Significance of Polymorphisms in Immune Response Genes in Hepatitis C-Related Hepatocellular Carcinoma

148. Bone marrow fibroblasts overexpress miR-27b and miR-214 in step with multiple myeloma progression, dependent on tumour cell-derived exosomes

149. Central Function for JAM-a in Multiple Myeloma Patients with Extramedullary Disease

Catalog

Books, media, physical & digital resources